Chart of Day: Cannabis Stocks – 1/17

Cannabis stocks could see higher highs.

“Marijuana should be rescheduled as a Schedule III drug as the plant does appear to have medical uses and is less dangerous than other drugs, according to a just made public HHS document,” as noted by Seeking Alpha. “Addressing a 252-page review, HHS Assistant Secretary for Health Rachel Levine wrote that based on evaluations from FDA scientists, cannabis should become a Schedule III substance.”

As a result of that news, several cannabis stocks are being bid higher, including Curaleaf Holdings (CURLF – up 7%), Green Thumb Industries (GTBIF- up about 11%), and Trulieve Cannabis (TCNNF – up 9%) on the news.


According to CNN, “Rescheduling marijuana could open up more avenues for research, allow cannabis businesses to bank more freely and openly, and have firms no longer subject to a 40-year-old tax code that disallows credits and deductions from income generated by sales of Schedule I and II substances.”

Now, as we near the 2024 U.S. presidential election, there’s speculation we could see further action on legalization efforts.

deal of the month

best growth stocks


Bundle package – lifetime subscriptions for all products


Recent posts


Connect with Us

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.